Changes in Right Ventricular Structure and Function Assessed Using Cardiac Magnetic Resonance Imaging in Bosentan-Treated Patients With Pulmonary Arterial Hypertension

American Journal of Cardiology

Volumn 101, Issue 11, 2008, Pages 1669-1672

  Chin, Kelly M ^a   Kingman, Martha ^a   de Lemos, James A ^a   Warner, John J ^a   Reimold, Sharon ^a   Peshock, Ron ^a   Torres, Fernando ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; ILOPROST; PROSTACYCLIN; SILDENAFIL; UNIPROST;

ADD ON THERAPY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG DOSE INCREASE; DRUG EFFECT; EXERCISE; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART INDEX; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; STATISTICAL SIGNIFICANCE; SURVIVAL; TREATMENT RESPONSE; WALKING;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; HYPERTENSION, PULMONARY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PULMONARY WEDGE PRESSURE; RETROSPECTIVE STUDIES; STROKE VOLUME; SULFONAMIDES; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, RIGHT;

EID: 43549106549     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.01.055     Document Type: Article

References (16)

1. Blyth K.G., Groenning B.A., Martin T.N., Foster J.E., Mark P.B., Dargie H.J., and Peacock A.J. Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 26 (2005) 1993-1999
2. Hoeper M.M., Tongers J., Leppert A., Baus S., Maier R., and Lotz J. Evaluation of right ventricular performance with a right ventricular ejection fraction thermodilution catheter and MRI in patients with pulmonary hypertension. Chest 120 (2001) 502-507
3. Simonneau G., Galie N., Rubin L.J., Langleben D., Seeger W., Domenighetti G., Gibbs S., Lebrec D., Speich R., Beghetti M., Rich S., and Fishman A. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43 suppl S (2004) 5S-12S
4. Lorenz C.H., Walker E.S., Morgan V.L., Klein S.S., and Graham T.P. Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson 1 (1999) 7-21
5. van Wolferen S.A., Marcus J.T., Boonstra A., Marques K.M., Bronzwaer J.G., Spreeuwenberg M.D., Postmus P.E., and Vonk-Noordegraaf A. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 28 (2007) 1250-1257
6. Raymond R.J., Hinderliter A.L., Willis P.W., Ralph D., Caldwell E.J., Williams W., Ettinger N.A., Hill N.S., Summer W.R., de Boisblanc B., et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 39 (2002) 1214-1219
7. Sitbon O., Humbert M., Nunes H., Parent F., Garcia G., Hervé P., Rainisio M., and Simonneau G. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 40 (2002) 780-788
8. McLaughlin V.V., Presberg K.W., Doyle R.L., Abman S.H., McCrory D.C., Fortin T., and Ahearn G. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 suppl (2004) 78S-92S
9. Park M.H., Scott R.L., Uber P.A., Ventura H.O., and Mehra M.R. Usefulness of B-type natriuretic peptide as a predictor of treatment outcome in pulmonary arterial hypertension. Congest Heart Fail 10 (2004) 221-225
10. Nagaya N., Nishikimi T., Uematsu M., Satoh T., Kyotani S., Sakamaki F., Kakishita M., Fukushima K., Okano Y., Nakanishi N., Miyatake K., and Kangawa K. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 102 (2000) 865-870
11. Channick R.N., Simonneau G., Sitbon O., Robbins I.M., Frost A., Tapson V.F., Badesch D.B., Roux S., Rainisio M., Bodin F., and Rubin L.J. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet 358 (2001) 1119-1123
12. Roeleveld R.J., Vonk-Noordegraaf A., Marcus J.T., Bronzwaer J.G., Marques K.M., Postmus P.E., and Boonstra A. Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension. Chest 125 (2004) 572-579
13. Galie N., Hinderliter A.L., Torbicki A., Fourme T., Simonneau G., Pulido T., Espinola-Zavaleta N., Rocchi G., Manes A., Frantz R., et al. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol 41 (2003) 1380-1386
14. Hinderliter A.L., Willis PW I.V., Barst R.J., Rich S., Rubin L.J., Badesch D.B., Groves B.M., McGoon M.D., Tapson V.F., Bourge R.C., et al. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. Circulation 95 (1997) 1479-1486
15. Kasimir M.T., Seebacher G., Jaksch P., Winkler G., Schmid K., Marta G.M., Simon P., and Klepetko W. Reverse cardiac remodeling in patients with primary pulmonary hypertension after isolated lung transplantation. Eur J Cardiothorac Surg 26 (2004) 776-781
16. Reesink H.J., Marcus J.T., Tulevski I.I., Jamieson S., Kloek J.J., Vonk Noordegraaf A., and Bresser P. Reverse right ventricular remodeling after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: utility of magnetic resonance imaging to demonstrate restoration of the right ventricle. J Thorac Cardiovasc Surg 133 (2007) 58-64